Literature DB >> 33689107

Convolutional neural network for classifying primary liver cancer based on triple-phase CT and tumor marker information: a pilot study.

Hirotsugu Nakai1, Koji Fujimoto2,3, Rikiya Yamashita4, Toshiyuki Sato2, Yuko Someya2, Kojiro Taura5, Hiroyoshi Isoda2,6, Yuji Nakamoto2.   

Abstract

PURPOSE: To develop convolutional neural network (CNN) models for differentiating intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC) and predicting histopathological grade of HCC.
MATERIALS AND METHODS: Preoperative computed tomography and tumor marker information of 617 primary liver cancer patients were retrospectively collected to develop CNN models categorizing tumors into three categories: moderately differentiated HCC (mHCC), poorly differentiated HCC (pHCC), and ICC, where the histopathological diagnoses were considered as ground truths. The models processed manually cropped tumor with and without tumor marker information (two-input and one-input models, respectively). Overall accuracy was assessed using a held-out dataset (10%). Area under the curve, sensitivity, and specificity for differentiating ICC from HCCs (mHCC + pHCC), and pHCC from mHCC were also evaluated. We assessed two radiologists' performance without tumor marker information as references (overall accuracy, sensitivity, and specificity). The two-input model was compared with the one-input model and radiologists using permutation tests.
RESULTS: The overall accuracy was 0.61, 0.60, 0.55, 0.53 for the two-input model, one-input model, radiologist 1, and radiologist 2, respectively. For differentiating pHCC from mHCC, the two-input model showed significantly higher specificity than radiologist 1 (0.68 [95% confidence interval: 0.50-0.83] vs 0.45 [95% confidence interval: 0.27-0.63]; p = 0.04).
CONCLUSION: Our CNN model with tumor marker information showed feasibility and potential for three-class classification within primary liver cancer.

Entities:  

Keywords:  Cholangiocellular carcinoma; Computed tomography; Deep learning; Hepatocellular cancer; Tumor grading; X-ray

Mesh:

Year:  2021        PMID: 33689107     DOI: 10.1007/s11604-021-01106-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  14 in total

Review 1.  Deep Learning: A Primer for Radiologists.

Authors:  Gabriel Chartrand; Phillip M Cheng; Eugene Vorontsov; Michal Drozdzal; Simon Turcotte; Christopher J Pal; Samuel Kadoury; An Tang
Journal:  Radiographics       Date:  2017 Nov-Dec       Impact factor: 5.333

Review 2.  Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.

Authors:  Bruno Daniele; Alfonso Bencivenga; Angelo Salomone Megna; Vincenza Tinessa
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

3.  Clinicopathologic features of poorly differentiated hepatocellular carcinoma.

Authors:  Koichi Oishi; Toshiyuki Itamoto; Hironobu Amano; Saburo Fukuda; Hideki Ohdan; Hirotaka Tashiro; Fumio Shimamoto; Toshimasa Asahara
Journal:  J Surg Oncol       Date:  2007-03-15       Impact factor: 3.454

Review 4.  Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.

Authors:  Nieun Seo; Do Young Kim; Jin-Young Choi
Journal:  AJR Am J Roentgenol       Date:  2017-06-01       Impact factor: 3.959

5.  CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.

Authors:  Akihiro Nishie; Kengo Yoshimitsu; Daisuke Okamoto; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Tomohiro Nakayama; Yukihisa Takayama; Ken Shirabe; Nobuhiro Fujita; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2012-10-17       Impact factor: 2.374

Review 6.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.

Authors:  Victoria Chernyak; Kathryn J Fowler; Aya Kamaya; Ania Z Kielar; Khaled M Elsayes; Mustafa R Bashir; Yuko Kono; Richard K Do; Donald G Mitchell; Amit G Singal; An Tang; Claude B Sirlin
Journal:  Radiology       Date:  2018-09-25       Impact factor: 11.105

7.  Deep Learning with Convolutional Neural Network for Differentiation of Liver Masses at Dynamic Contrast-enhanced CT: A Preliminary Study.

Authors:  Koichiro Yasaka; Hiroyuki Akai; Osamu Abe; Shigeru Kiryu
Journal:  Radiology       Date:  2017-10-23       Impact factor: 11.105

8.  In hepatocellular carcinomas, any proportion of poorly differentiated components is associated with poor prognosis after hepatectomy.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Yu Ohkura; Yusuke Kawamura; Masafumi Inoue; Masaji Hashimoto; Kenji Ikeda; Hiromitsu Kumada; Goro Watanabe
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

9.  Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma.

Authors:  Hana Park; Jun Yong Park
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

10.  Impact of PIVKA-II in diagnosis of hepatocellular carcinoma.

Authors:  Nadia I Zakhary; Sherif M Khodeer; Hanan E Shafik; Camelia A Abdel Malak
Journal:  J Adv Res       Date:  2013-01-11       Impact factor: 10.479

View more
  1 in total

Review 1.  Artificial intelligence and cholangiocarcinoma: Updates and prospects.

Authors:  Hossein Haghbin; Muhammad Aziz
Journal:  World J Clin Oncol       Date:  2022-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.